Hydatidiform mole
Hydatid mole; Molar pregnancy; Hyperemesis - molar
Hydatidiform mole (HM) is a rare mass or growth that forms inside the womb (uterus) at the beginning of a pregnancy. It is a type of gestational trophoblastic disease (GTD).
![Uterus](https://ssl.adam.com/graphics/images/en/19263.jpg)
The uterus is a hollow muscular organ located in the female pelvis between the bladder and rectum. The ovaries produce the eggs that travel through the fallopian tubes. Once the egg has left the ovary it can be fertilized and implant itself in the lining of the uterus. The main function of the uterus is to nourish the developing fetus prior to birth.
![Normal uterine anatomy (cut section)](https://ssl.adam.com/graphics/images/en/8608.jpg)
The uterus is a muscular organ with thick walls, two upper openings to the fallopian tubes and an inferior opening to the vagina.
Causes
HM, or molar pregnancy, results from abnormal fertilization of the oocyte (egg). It results in an abnormal fetus. The placenta grows normally with little or no growth of the fetal tissue. The placental tissue forms a mass in the uterus. On ultrasound, this mass often has a grape-like appearance, as it contains many small cysts.
The chance of mole formation is higher in older women. A history of mole in earlier years is also a risk factor.
Molar pregnancy can be of two types:
- Partial molar pregnancy: There is an abnormal placenta and some fetal development.
- Complete molar pregnancy: There is an abnormal placenta and no fetus.
There is no way to prevent formation of these masses.
Symptoms
Symptoms of a molar pregnancy may include:
- Abnormal growth of the uterus, either bigger or smaller than usual
- Severe nausea and vomiting
- Vaginal bleeding during the first 3 months of pregnancy
- Symptoms of hyperthyroidism, including heat intolerance, loose stools, rapid heart rate, restlessness or nervousness, warm and moist skin, trembling hands, or unexplained weight loss
- Symptoms similar to preeclampsia that occur in the first trimester or early second trimester, including high blood pressure and swelling in the feet, ankles, and legs (this is almost always a sign of a hydatidiform mole, because preeclampsia is extremely rare this early in a normal pregnancy)
Exams and Tests
Your health care provider will perform a pelvic exam, which may show signs similar to a normal pregnancy. However, the size of the womb may be abnormal and there may be no heart sounds from the baby. Also, there may be some vaginal bleeding.
A pregnancy ultrasound will show a snowstorm appearance with an abnormal placenta, with or without some development of a baby.
Tests done may include:
- hCG (or HCG, both quantitative) blood test
- Abdominal or vaginal ultrasound of the pelvis
- Chest x-ray
- CT or MRI of the abdomen (imaging tests)
- Complete blood count (CBC)
- Blood clotting tests
- Kidney and liver function tests
Treatment
If your provider suspects a molar pregnancy, removal of the abnormal tissue with a dilation and curettage (D&C) will most likely be suggested. D&C may also be done using suction. This is called suction aspiration (The method uses a suction cup to remove contents from the uterus).
Very rarely, a partial molar pregnancy can continue. A woman may choose to continue her pregnancy in the hope of having a successful birth and delivery. However, these are very high-risk pregnancies. Risks may include bleeding, problems with blood pressure, and premature delivery (having the baby before it is fully developed). In rare cases, the fetus is genetically normal. Women need to completely discuss the risks with their provider before continuing the pregnancy.
A hysterectomy (surgery to remove the uterus) may be an option for older women who do not wish to become pregnant in the future.
After treatment, your hCG level will be followed. It is important to avoid another pregnancy and to use a reliable contraceptive for 6 to 12 months after treatment for a molar pregnancy. This time allows for accurate testing to be sure that the abnormal tissue does not grow back. Women who get pregnant too soon after a molar pregnancy are at high risk of having another molar pregnancy.
Outlook (Prognosis)
Most HMs are noncancerous (benign). Treatment is usually successful. Close follow-up by your provider is important to ensure that signs of the molar pregnancy are gone and pregnancy hormone levels return to normal.
About 15% of cases of HM can become invasive. These moles can grow deep into the uterine wall and cause bleeding or other complications. This type of mole most often responds well to medicines.
In very few cases of complete HM, moles develop into a choriocarcinoma. This is a fast-growing cancer. It is usually successfully treated with chemotherapy, but can be life threatening.
Possible Complications
Complications of molar pregnancy may include:
- Change to invasive molar disease or choriocarcinoma
- Preeclampsia
- Thyroid problems
- Molar pregnancy that continues or comes back
Complications from surgery to remove a molar pregnancy may include:
- Excessive bleeding, possibly requiring a blood transfusion
- Side effects of anesthesia
References
Henn MC, Lall MD. Complications of pregnancy. In: Walls RM, ed. Rosen's Emergency Medicine: Concepts and Clinical Practice. 10th ed. Philadelphia, PA: Elsevier; 2023:chap 173.
Nica A, Bouchard-Fortier G, Covens A. Gestational trophoblastic disease: hydatidiform mole, nonmetastatic and metastatic gestational trophoblastic tumor: diagnosis and management. In: Gershenson DM, Lentz GM, Valea FA, Lobo RA, eds. Comprehensive Gynecology. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 34.
Soper JT. Gestational trophoblastic disease. In: Creasman WT, Mutch DG, Mannel RS, Tewari KS, eds. DiSaia and Creasman Clinical Gynecologic Oncology. 10th ed. Philadelphia, PA: Elsevier; 2023:chap 7.
Tidy J. Gestational trophoblastic disease. In: Magowan B, ed. Clinical Obstetrics and Gynaecology. 5th ed. Philadelphia, PA: Elsevier Limited; 2023:chap 15.
Version Info
Last reviewed on: 11/10/2022
Reviewed by: John D. Jacobson, MD, Department of Obstetrics and Gynecology, Loma Linda University School of Medicine, Loma Linda, CA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
![ADAM Logo](/mshealth/themes/default/media/images/adamsquarequart.gif)